My Reports
RGCIRC, Niti Bagh
Rhabdomyosarcoma Treatment in Delhi at RGCIRC
Rhabdomyosarcoma is a rare and aggressive soft tissue cancer that primarily affects children and young adults, requiring highly specialised and timely care. At RGCIRC (Rajiv Gandhi Cancer Institute & Research Centre), Delhi, we provide advanced, evidence-based treatment for rhabdomyosarcoma through a multidisciplinary approach that combines medical expertise, precision diagnostics, and personalised treatment planning. Our experienced paediatric and medical oncology teams work closely with surgical oncologists, radiation specialists, and supportive care experts to deliver comprehensive care at every stage of the disease. With access to advanced chemotherapy protocols, precision radiation techniques, and complex cancer surgeries, RGCIRC is committed to improving outcomes while prioritising safety, quality of life, and long-term follow-up for patients and their families.
What is Rhabdomyosarcoma?
Rhabdomyosarcoma is a type of soft tissue sarcoma that arises from immature cells destined to form skeletal muscle. Although skeletal muscle is found throughout the body, rhabdomyosarcoma can develop in areas where muscle tissue is minimal or not easily visible, such as the head and neck region, the urinary and reproductive organs, the trunk, or the arms and legs.
This cancer is seen most often in children and adolescents, but it can occasionally occur in adults. Rhabdomyosarcoma tends to grow quickly, which makes early detection and prompt treatment especially important. The behaviour of the disease, as well as the choice and intensity of treatment, depends on factors such as the tumour’s location, size, spread, and biological subtype.
At RGCIRC, specialists focus on accurate diagnosis and careful classification of rhabdomyosarcoma to ensure that each patient receives appropriately tailored, risk-adapted care.
Causes and Risk Factors of Rhabdomyosarcoma
The exact cause of rhabdomyosarcoma is not fully understood. It is believed to develop when immature muscle cells undergo genetic changes that cause them to grow and divide uncontrollably. In most children, these changes occur sporadically, without a clear trigger. While rhabdomyosarcoma is rare, certain factors may increase the risk of developing this cancer.
Key risk factors include:
- Age: Rhabdomyosarcoma is more commonly diagnosed in children and adolescents, particularly in early childhood.
- Genetic conditions: Rare inherited disorders, such as Li-Fraumeni syndrome, neurofibromatosis type 1, and Beckwith-Wiedemann syndrome, are associated with a higher risk.
- Family history: Although uncommon, a family history of specific cancer syndromes may increase susceptibility.
- Congenital abnormalities: Some children with certain birth defects may have a slightly higher risk of developing rhabdomyosarcoma.
It is important to note that most children diagnosed with rhabdomyosarcoma do not have any identifiable risk factors. At RGCIRC, specialists focus on early recognition, accurate diagnosis, and timely treatment rather than prevention, as there is currently no known way to prevent this cancer.
Types of Rhabdomyosarcoma
Rhabdomyosarcoma is classified into different types based on how the cancer cells look under a microscope and how the disease behaves. Identifying the exact type is important, as it helps guide treatment planning and provides information about how the tumour may respond to therapy. At RGCIRC, detailed pathological evaluation ensures accurate classification before treatment begins.
Common types of Rhabdomyosarcoma include:
1. Embryonal Rhabdomyosarcoma
This is the most common type of rhabdomyosarcoma and is usually seen in younger children. It often develops in the head and neck region, urinary bladder, or reproductive organs. Embryonal rhabdomyosarcoma generally responds well to treatment when managed early with a multimodal approach.
2. Alveolar Rhabdomyosarcoma
Alveolar rhabdomyosarcoma is less common but more aggressive and is often diagnosed in older children and adolescents. It typically affects the arms, legs, chest, or abdomen and may spread more quickly, requiring intensive and carefully coordinated treatment.
3. Pleomorphic Rhabdomyosarcoma
This rare type is more commonly seen in adults. It behaves differently from childhood forms of rhabdomyosarcoma and is managed using treatment strategies tailored to adult soft tissue sarcomas.
Signs and Symptoms of Rhabdomyosarcoma
The signs and symptoms of rhabdomyosarcoma vary depending on the tumour’s location and size. In many cases, the disease may initially present as a painless swelling, which can be easily overlooked. As the tumour grows, it may press on nearby organs, nerves, or structures, leading to more noticeable symptoms.
Common signs and symptoms include:
- A painless lump or swelling that may gradually increase in size
- Pain or discomfort if the tumour presses on surrounding tissues or nerves
- Symptoms related to tumour location, such as:
- Head and neck tumours: nasal blockage, nosebleeds, facial swelling, eye bulging, or headaches
- Tumours near the brain or meninges: neurological symptoms or persistent headaches
- Genitourinary tumours: blood in urine, difficulty urinating, or abdominal swelling
- Limb tumours: restricted movement, swelling, or pain in the arms or legs
- General symptoms include fever, fatigue, or unexplained weight loss in advanced cases
Any persistent or unusual swelling, especially in children, should be evaluated promptly. At RGCIRC, early assessment and diagnosis help ensure timely treatment and improved outcomes for children with rhabdomyosarcoma.
Diagnosis of Rhabdomyosarcoma at RGCIRC
Accurate and timely diagnosis is essential for confirming rhabdomyosarcoma and planning appropriate, risk-adapted treatment. At RGCIRC, we follow a structured, child-centred approach that combines clinical evaluation, advanced imaging, and specialised pathology. The diagnostic approach include:
Clinical Assessment
The diagnostic process begins with a detailed medical history and physical examination to understand the child’s symptoms, tumour location, and overall health status. This initial assessment helps guide further investigations.
Imaging Studies
Imaging plays a crucial role in defining the tumour’s size, location, and extent of spread. Depending on the clinical situation, the following tests may be advised:
- MRI or CT scans to evaluate the primary tumour and its relationship with nearby organs and tissues
- PET-CT scans in selected cases to assess disease spread and staging
Biopsy and Tissue Diagnosis
A biopsy is essential to confirm rhabdomyosarcoma and determine its specific type. During this step:
- A tissue sample is obtained from the tumour
- Specialised pathologists examine the sample to identify rhabdomyosarcoma and its histological subtype
Additional Tests (When Required)
To support diagnosis and treatment planning, additional investigations may be recommended in certain cases:
- Blood tests, including complete blood count (CBC), to assess overall health and treatment readiness
- Bone marrow examination or lumbar puncture in specific high-risk or site-related cases
By integrating clinical findings, imaging results, and detailed pathological analysis, the multidisciplinary team at RGCIRC ensures precise diagnosis and staging, allowing treatment to begin promptly and safely.
Stages of Rhabdomyosarcoma
Staging describes how far rhabdomyosarcoma has spread at the time of diagnosis. It helps doctors understand the extent of the disease and plan the sequence of treatment. At RGCIRC, staging is determined using imaging studies, biopsy findings, and surgical assessment.
The stage of rhabdomyosarcoma is based on several factors, including:
- The size and location of the primary tumour
- Whether the tumour has spread to nearby lymph nodes
- Whether there is spread to distant organs, such as the lungs, bone marrow, or brain
Early-stage disease is limited to the original site, while advanced stages indicate regional or distant spread. Accurate staging is essential to ensure timely and appropriate treatment planning.
Risk Groups in Rhabdomyosarcoma
In addition to staging, rhabdomyosarcoma is classified into risk groups, which guide the intensity of treatment. Risk grouping takes into account not only how far the cancer has spread, but also how it is likely to behave and respond to therapy.
Risk groups are determined based on:
- Tumour stage
- Histological type (such as embryonal or alveolar)
- Tumour location
- Extent of tumour removal during surgery
- Presence or absence of metastasis
Based on these factors, patients are broadly categorised into:
- Low-risk group, where treatment aims to achieve cure with reduced intensity to limit long-term side effects
- Intermediate-risk group, which requires a combination of chemotherapy, surgery, and sometimes radiation therapy
- High-risk group, where more intensive multimodal treatment is needed due to aggressive tumour behaviour or spread
At RGCIRC, risk grouping allows specialists to personalise treatment, ensuring that children with less aggressive disease avoid unnecessary toxicity, while those with higher-risk disease receive comprehensive, closely monitored care.
Treatment Options for Rhabdomyosarcoma at RGCIRC
Treatment for rhabdomyosarcoma requires a carefully coordinated, multimodal approach tailored to the child’s tumour type, location, stage, and risk group. At RGCIRC, paediatric oncologists, surgical oncologists, radiation oncologists, and supportive care specialists work together to deliver evidence-based, risk-adapted treatment with a strong focus on cure, functional preservation, and long-term wellbeing. Treatment approaches include:
Chemotherapy
Chemotherapy is a core component of rhabdomyosarcoma treatment and is used in almost all cases. It helps destroy cancer cells throughout the body and reduces the risk of recurrence. Treatment is given in planned cycles and may be administered before surgery to shrink the tumour or after surgery to eliminate remaining cancer cells. The choice of drugs and duration of chemotherapy depend on the child’s risk group and response to treatment.
Surgical Treatment
Surgery aims to remove as much of the tumour as safely possible while preserving surrounding organs and function. The surgical approach depends on the tumour’s size and location. In many cases, surgeons focus on organ- and function-preserving techniques, especially when tumours involve the head and neck region, urinary system, or limbs. When complete removal is not possible, surgery is combined with other treatments to achieve optimal control.
Radiation Therapy
Radiation therapy is used when surgery cannot completely remove the tumour or when tumour location makes surgical removal difficult. It may also be recommended for certain higher-risk tumours. At RGCIRC, radiation therapy is planned with precision to target cancer cells effectively while minimising exposure to healthy tissues, which is particularly important in growing children.
Multidisciplinary and Risk-Adapted Treatment Planning
Every child with rhabdomyosarcoma at RGCIRC is discussed in a multidisciplinary tumour board meeting. Treatment intensity is adjusted according to the risk group, ensuring that children with low-risk disease receive effective treatment with fewer long-term side effects, while those with higher-risk disease benefit from comprehensive, intensive care.
Support, Recovery, and Long-Term Care
Treatment for rhabdomyosarcoma does not end with tumour control alone. Recovery and long-term wellbeing are equally important, particularly for children who are still growing and developing. At RGCIRC, supportive and rehabilitative care is integrated throughout the treatment journey to help children recover safely and maintain the best possible quality of life.
Managing Treatment-Related Side Effects
Children undergoing chemotherapy, surgery, or radiation therapy may experience temporary side effects. The care team at RGCIRC closely monitors each child and provides timely support to manage:
- Fatigue, nausea, or appetite changes related to chemotherapy
- Pain or discomfort following surgery
- Skin irritation or sensitivity after radiation therapy
Early intervention helps reduce discomfort and supports smoother recovery.
Nutritional and Growth Support
Good nutrition plays a vital role in healing and development during and after treatment. Dieticians work closely with families to:
- Support adequate calorie and nutrient intake for growth
- Manage feeding difficulties or reduced appetite
- Monitor weight, hydration, and nutritional status throughout recovery
Rehabilitation and Functional Recovery
When treatment affects movement, speech, or daily activities, rehabilitation services are introduced early. Physiotherapy, occupational therapy, or speech therapy may be recommended to help children regain strength, coordination, and independence.
Psychological and Emotional Support
A cancer diagnosis can be emotionally challenging for both children and their families. RGCIRC provides access to counselling and child-focused psychological support to help:
- Children cope with fear, anxiety, or changes in routine
- Parents and caregivers manage emotional stress
- Families adjust during treatment and recovery
Long-Term Follow-Up and Survivorship Care
Regular follow-up is essential to monitor recovery, detect any recurrence early, and manage long-term effects of treatment. Follow-up care may include:
- Periodic imaging and clinical assessments
- Monitoring growth, development, and organ function
- Guidance on returning to school, play, and normal activities
Through comprehensive supportive care and structured follow-up, RGCIRC ensures that children treated for rhabdomyosarcoma receive continued care focused on recovery, development, and long-term health.
Why RGCIRC is a Trusted Centre for Rhabdomyosarcoma Treatmen
Treating rhabdomyosarcoma requires specialised expertise, advanced infrastructure, and a deeply coordinated approach to paediatric cancer care. RGCIRC is recognised for its comprehensive management of childhood cancers, offering evidence-based treatment supported by experienced specialists and child-focused support services. Here’s why RGCIRC is a trusted centre for rhabdomyosarcoma treatment:
Expert Paediatric Oncology Team
RGCIRC is home to highly skilled and renowned paediatric oncologists, surgical oncologists, radiation oncologists, and specialised nursing teams with extensive experience in managing rare childhood cancers such as rhabdomyosarcoma. Their expertise ensures accurate diagnosis, appropriate risk stratification, and carefully planned treatment for each child.
Multidisciplinary, Risk-Adapted Care
Every case is reviewed by a multidisciplinary tumour board that brings together experts from paediatric oncology, surgery, radiation therapy, radiology, pathology, and rehabilitation. This collaborative approach ensures that treatment intensity is tailored to the child’s risk group, balancing cure with long-term safety and quality of life.
Advanced Diagnostic and Treatment Facilities
RGCIRC is equipped with advanced imaging, precision radiation technology, and modern surgical facilities designed to support accurate tumour evaluation and safe treatment delivery. These resources are particularly important for complex tumour locations and growing children.
Child-Centred Supportive Care Environment
Care at RGCIRC extends beyond medical treatment. Child-friendly facilities, dedicated paediatric nursing, nutritional guidance, psychological support, and rehabilitation services help children and families feel supported throughout diagnosis, treatment, and recovery.
Commitment to Long-Term Outcomes
RGCIRC places strong emphasis on survivorship and long-term follow-up, focusing on growth, development, organ function, and emotional wellbeing. Structured follow-up programmes help children transition back to daily life while maintaining close medical supervision.
Research-Guided and Evidence-Based Cancer Care
At RGCIRC, cancer treatment is guided by established clinical evidence and continuously evolving research in oncology. Treatment protocols are aligned with international guidelines and refined through multidisciplinary tumour board discussions, outcome analysis, and academic engagement. This research-driven approach ensures that each patient receives care that reflects current best practices-balancing treatment effectiveness with safety, long-term health, and quality of life.
Through its combination of specialised expertise, advanced technology, and compassionate care, RGCIRC continues to be a trusted centre for rhabdomyosarcoma treatment in Delhi and across India.
Book a Consultation at RGCIRC
Early diagnosis and timely, specialised treatment play a critical role in managing rhabdomyosarcoma effectively. Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) offers comprehensive diagnostic services, risk-adapted treatment, and multidisciplinary paediatric oncology care for children with rhabdomyosarcoma. To consult an experienced paediatric oncologist or schedule an appointment, simply call +91-11-47022222, +91 11 27051037.
Frequently Asked Questions (FAQs)
What is rhabdomyosarcoma?
Rhabdomyosarcoma is a rare type of soft tissue cancer that develops from immature muscle cells. It most commonly affects children and adolescents and can occur in various parts of the body.
Is rhabdomyosarcoma a childhood cancer?
Yes. Rhabdomyosarcoma is most often diagnosed in children, although it can occasionally occur in adolescents and adults.
What are the early symptoms of rhabdomyosarcoma?
Early symptoms may include a painless lump or swelling, pain due to pressure on nearby structures, or symptoms related to the tumour’s location, such as nasal blockage or urinary difficulties.
How is rhabdomyosarcoma diagnosed?
Diagnosis involves imaging tests such as MRI or CT scans, followed by a biopsy to confirm the cancer type. Additional tests may be done to assess spread and overall health.
Is rhabdomyosarcoma treatable?
Yes. Rhabdomyosarcoma is treatable, especially when diagnosed early. Treatment typically involves a combination of chemotherapy, surgery, and radiation therapy, tailored to the child’s risk group.
How long does treatment for rhabdomyosarcoma take?
Treatment duration varies depending on the tumour type, stage, and response to therapy. Most children require treatment over several months, followed by long-term follow-up.
Are there long-term effects after rhabdomyosarcoma treatment?
Some children may experience long-term effects related to treatment. Regular follow-up helps monitor growth, development, and organ function, allowing early management of any concerns.
How can I find a rhabdomyosarcoma treatment centre near me?
When seeking specialised care for rhabdomyosarcoma, it is important to choose a centre with experienced paediatric oncology specialists and multidisciplinary treatment planning. RGCIRC is a trusted centre for rhabdomyosarcoma treatment in Delhi and across India.
Can rhabdomyosarcoma recur after treatment?
Yes, rhabdomyosarcoma can recur in some cases, particularly in higher-risk disease. This is why regular follow-up after treatment is essential. At RGCIRC, children are monitored closely through scheduled clinical evaluations and imaging to detect any recurrence early and manage it promptly if it occurs.
What are the side effects of chemotherapy for rhabdomyosarcoma?
Chemotherapy may cause side effects, which vary depending on the medicines used and the child’s overall health. Common side effects can include fatigue, nausea, vomiting, hair loss, reduced appetite, and increased susceptibility to infections. Most side effects are temporary and can be managed with supportive care. At RGCIRC, paediatric oncology teams closely monitor children during treatment to minimise discomfort and address side effects early.
Is rhabdomyosarcoma life threatening?
Rhabdomyosarcoma is a serious and potentially life-threatening cancer if left untreated. However, with timely diagnosis and appropriate multimodal treatment, many children achieve good outcomes. Advances in chemotherapy, surgery, radiation therapy, and supportive care have significantly improved survival, especially when treatment is delivered at specialised cancer centres such as RGCIRC.